Matches in Wikidata for { <http://www.wikidata.org/entity/Q65363627> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q65363627 description "clinical trial" @default.
- Q65363627 description "ensayu clínicu" @default.
- Q65363627 description "klinisch onderzoek" @default.
- Q65363627 description "клінічне випробування" @default.
- Q65363627 name "Study to Assess Safety and Impact of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Pain Crises" @default.
- Q65363627 name "Study to Assess Safety and Impact of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Pain Crises" @default.
- Q65363627 type Item @default.
- Q65363627 label "Study to Assess Safety and Impact of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Pain Crises" @default.
- Q65363627 label "Study to Assess Safety and Impact of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Pain Crises" @default.
- Q65363627 prefLabel "Study to Assess Safety and Impact of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Pain Crises" @default.
- Q65363627 prefLabel "Study to Assess Safety and Impact of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Pain Crises" @default.
- Q65363627 P1132 Q65363627-4286CE66-6AC9-4DF9-AF51-CC1F6694A6DF @default.
- Q65363627 P1476 Q65363627-2AB8B9BC-8A4C-4764-9109-EC42543F48D6 @default.
- Q65363627 P17 Q65363627-131B4331-5F55-4C0F-A955-3650B51A5B27 @default.
- Q65363627 P17 Q65363627-DD626954-81C7-4877-9451-F12D50DE2ED0 @default.
- Q65363627 P17 Q65363627-F383BC78-FD36-4678-8406-4C94A0F4AB2A @default.
- Q65363627 P1813 Q65363627-68EB2878-275C-488E-B000-DCCDAA8D0CBB @default.
- Q65363627 P2899 Q65363627-A4634921-37F1-42E6-A64C-BC2C7CA89BBD @default.
- Q65363627 P3098 Q65363627-BBB94356-2B7B-4363-8CD3-68144FD373AD @default.
- Q65363627 P31 Q65363627-0653E5AF-FB53-4C00-AC24-12C90BBC08B6 @default.
- Q65363627 P4135 Q65363627-0B295D6D-C784-4010-8563-0995F3702E35 @default.
- Q65363627 P580 Q65363627-31A01A44-7CF6-4497-8C5C-6A340D8E45ED @default.
- Q65363627 P582 Q65363627-A0459167-1A26-46CC-8CE7-CBC168FC7996 @default.
- Q65363627 P6099 Q65363627-5588110D-AABE-48B9-921D-B3407989FCD6 @default.
- Q65363627 P8363 Q65363627-2B888AF5-E6B9-48B1-BC0B-58553D55638C @default.
- Q65363627 P1132 "+198" @default.
- Q65363627 P1476 "A Phase II, Multicenter, Randomized, Placebo-Controlled, Double-Blind, 12-Month Study to Assess Safety and Efficacy of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Sickle Cell-Related Pain Crises" @default.
- Q65363627 P17 Q155 @default.
- Q65363627 P17 Q30 @default.
- Q65363627 P17 Q766 @default.
- Q65363627 P1813 "SUSTAIN" @default.
- Q65363627 P2899 "+16" @default.
- Q65363627 P3098 "NCT01895361" @default.
- Q65363627 P31 Q30612 @default.
- Q65363627 P4135 "+65" @default.
- Q65363627 P580 "2013-07-01T00:00:00Z" @default.
- Q65363627 P582 "2016-03-01T00:00:00Z" @default.
- Q65363627 P6099 Q42824440 @default.
- Q65363627 P8363 Q78089383 @default.